214 related articles for article (PubMed ID: 16979275)
21. Tryptophan hydroxylase 1 gene (TPH1) moderates the influence of social support on depressive symptoms in adults.
Jokela M; Räikkönen K; Lehtimäki T; Rontu R; Keltikangas-Järvinen L
J Affect Disord; 2007 Jun; 100(1-3):191-7. PubMed ID: 17134762
[TBL] [Abstract][Full Text] [Related]
22. Association between the TPH1 A218C polymorphism and antidepressant response: evidence from an updated ethnicity, antidepressant-specific, and ethnicity-antidepressant interaction meta-analysis.
Zhao X; Huang Y; Li D; Han C; Kan Q
Psychiatr Genet; 2015 Feb; 25(1):1-8. PubMed ID: 25419635
[TBL] [Abstract][Full Text] [Related]
23. Citalopram neuropharmacological challenge in alcohol-dependent patients and controls: pharmacogenetic, endocrine and psychobehavioral results.
Wong WM; Hasemann S; Schwarz M; Zill P; Koller G; Soyka M; Preuss UW
Pharmacopsychiatry; 2008 Mar; 41(2):72-8. PubMed ID: 18311688
[TBL] [Abstract][Full Text] [Related]
24. Tryptophan hydroxylase gene (TPH1) and peripheral tryptophan levels in depression.
Porter RJ; Mulder RT; Joyce PR; Miller AL; Kennedy M
J Affect Disord; 2008 Jul; 109(1-2):209-12. PubMed ID: 18177948
[TBL] [Abstract][Full Text] [Related]
25. Genetic variability at HPA axis in major depression and clinical response to antidepressant treatment.
Papiol S; Arias B; Gastó C; Gutiérrez B; Catalán R; Fañanás L
J Affect Disord; 2007 Dec; 104(1-3):83-90. PubMed ID: 17467808
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
27. Association of tryptophan hydroxylase gene polymorphism with depression, anxiety and comorbid depression and anxiety in a population-based sample of postpartum Taiwanese women.
Sun HS; Tsai HW; Ko HC; Chang FM; Yeh TL
Genes Brain Behav; 2004 Dec; 3(6):328-36. PubMed ID: 15544576
[TBL] [Abstract][Full Text] [Related]
28. No association of serotonin transporter polymorphism (5-HTTVNTR and 5-HTTLPR) with characteristics and treatment response to atypical antipsychotic agents in schizophrenic patients.
Lee HY; Kim DJ; Lee HJ; Choi JE; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):276-80. PubMed ID: 19059448
[TBL] [Abstract][Full Text] [Related]
29. Somatization in major depression--clinical features and genetic associations.
Klengel T; Heck A; Pfister H; Brückl T; Hennings JM; Menke A; Czamara D; Müller-Myhsok B; Ising M
Acta Psychiatr Scand; 2011 Oct; 124(4):317-28. PubMed ID: 21838737
[TBL] [Abstract][Full Text] [Related]
30. The association between serotonin-related gene polymorphisms and panic disorder.
Yoon HK; Yang JC; Lee HJ; Kim YK
J Anxiety Disord; 2008 Dec; 22(8):1529-34. PubMed ID: 18436425
[TBL] [Abstract][Full Text] [Related]
31. TPH1 A218C polymorphism and temperament in major depression.
Andre K; Kampman O; Viikki M; Illi A; Setälä-Soikkeli E; Poutanen O; Mononen N; Leinonen E; Lehtimäki T
BMC Psychiatry; 2013 Apr; 13():118. PubMed ID: 23597148
[TBL] [Abstract][Full Text] [Related]
32. Failure to replicate genetic associations with antidepressant treatment response in duloxetine-treated patients.
Perlis RH; Fijal B; Dharia S; Heinloth AN; Houston JP
Biol Psychiatry; 2010 Jun; 67(11):1110-3. PubMed ID: 20110084
[TBL] [Abstract][Full Text] [Related]
33. No interactions between genetic polymorphisms and stressful life events on outcome of antidepressant treatment.
Bukh JD; Bock C; Vinberg M; Werge T; Gether U; Kessing LV
Eur Neuropsychopharmacol; 2010 May; 20(5):327-35. PubMed ID: 20022223
[TBL] [Abstract][Full Text] [Related]
34. Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment.
Tzvetkov MV; Brockmöller J; Roots I; Kirchheiner J
Pharmacogenet Genomics; 2008 Jun; 18(6):495-506. PubMed ID: 18496129
[TBL] [Abstract][Full Text] [Related]
35. Serotonin-related gene pathways associated with undifferentiated somatoform disorder.
Koh KB; Choi EH; Lee YJ; Han M
Psychiatry Res; 2011 Sep; 189(2):246-50. PubMed ID: 21531467
[TBL] [Abstract][Full Text] [Related]
36. Does pretreatment testing for serotonin transporter polymorphisms lead to earlier effects of drug treatment in patients with major depression? A decision-analytic model.
Smits KM; Smits LJ; Schouten JS; Peeters FP; Prins MH
Clin Ther; 2007 Apr; 29(4):691-702. PubMed ID: 17617292
[TBL] [Abstract][Full Text] [Related]
37. Tryptophan hydroxylase gene associated with paroxetine antidepressant activity.
Serretti A; Zanardi R; Cusin C; Rossini D; Lorenzi C; Smeraldi E
Eur Neuropsychopharmacol; 2001 Oct; 11(5):375-80. PubMed ID: 11597824
[TBL] [Abstract][Full Text] [Related]
38. No association of TPH1 218A/C polymorphism with treatment response and intolerance to SSRIs in Japanese patients with major depression.
Kato M; Wakeno M; Okugawa G; Fukuda T; Azuma J; Kinoshita T; Serretti A
Neuropsychobiology; 2007; 56(4):167-71. PubMed ID: 18332644
[TBL] [Abstract][Full Text] [Related]
39. No association between the TPH A218C polymorphism and personality traits in Japanese healthy subjects.
Suzuki A; Fukasawa T; Shiraishi H; Ishii G; Oshino S; Aoshima T; Otani K
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):395-8. PubMed ID: 17116352
[TBL] [Abstract][Full Text] [Related]
40. The role of the TPH1 and TPH2 genes for nicotine dependence: a genetic association study in two different age cohorts.
Reuter M; Hennig J; Amelang M; Montag C; Korkut T; Hueweler A; Stürmer T
Neuropsychobiology; 2007; 56(1):47-54. PubMed ID: 17986837
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
